<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical &#38; Health Blog &#187; Diseases &amp; Conditions</title>
	<atom:link href="http://www.medicalapple.com/blog/category/diseases-conditions/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.medicalapple.com/blog</link>
	<description></description>
	<lastBuildDate>Fri, 09 Sep 2011 02:37:15 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>ADHD Medication</title>
		<link>http://www.medicalapple.com/blog/adhd-medication/</link>
		<comments>http://www.medicalapple.com/blog/adhd-medication/#comments</comments>
		<pubDate>Wed, 17 Dec 2008 07:32:42 +0000</pubDate>
		<dc:creator>Andy Johnson</dc:creator>
				<category><![CDATA[Diseases & Conditions]]></category>
		<category><![CDATA[ADHD Medication]]></category>
		<category><![CDATA[ADHD Therapy]]></category>
		<category><![CDATA[Methylphenidate Product]]></category>

		<guid isPermaLink="false">http://www.medicalapple.com/blog/?p=40</guid>
		<description><![CDATA[CONCERTA is a once-daily methylphenidate product that provides efficacy through 12 hours with one morning dose. Using proprietary OROS® delivery, CONCERTA is the only ADHD therapy that provides a gradual ascending release of methylphenidate throughout the day. Now, not only can children and adolescents with ADHD benefit from CONCERTA &#8211; adults with ADHD can too. [...]]]></description>
			<content:encoded><![CDATA[<p>CONCERTA is a once-daily <a href="http://www.concerta360.com"><strong>methylphenidate product</strong></a> that provides efficacy through 12 hours with one morning dose. Using proprietary OROS® delivery, CONCERTA is the only <a href="http://www.concerta360.com"><strong>ADHD therapy</strong></a> that provides a gradual ascending release of methylphenidate throughout the day.</p>
<p>Now, not only can children and adolescents with ADHD benefit from CONCERTA &#8211; adults with ADHD can too. CONCERTA is now approved by FDA for adults with ADHD, based on clinical trials with over 1,000 patients.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.medicalapple.com/blog/adhd-medication/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ERBITUX (Cetuximab)</title>
		<link>http://www.medicalapple.com/blog/admin/</link>
		<comments>http://www.medicalapple.com/blog/admin/#comments</comments>
		<pubDate>Fri, 12 Dec 2008 08:46:43 +0000</pubDate>
		<dc:creator>Anna</dc:creator>
				<category><![CDATA[Diseases & Conditions]]></category>
		<category><![CDATA[Colorectal Cancer]]></category>
		<category><![CDATA[Head & Neck Cancer]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://www.medicalapple.com/blog/?p=39</guid>
		<description><![CDATA[Learn about a treatment option for metastatic colorectal cancer and an initial treatment option for locally or regionally advanced head and neck cancer. Colon Cancer: ERBITUX (Cetuximab) is indicated for the treatment of patients who have colorectal cancer that has spread to other parts of the body and whose tumor expresses a protein called an [...]]]></description>
			<content:encoded><![CDATA[<p>Learn about a treatment option for metastatic <a href="http://erbitux.com/">colorectal cancer</a> and an initial treatment option for locally or regionally advanced <a href="http://erbitux.com/">head and neck cancer</a>.</p>
<p>Colon Cancer:<br />
ERBITUX (Cetuximab) is indicated for the treatment of patients who have colorectal cancer that has spread to other parts of the body and whose tumor expresses a protein called an Epidermal Growth Factor Receptor (EGFR).</p>
<p>Head &amp; Neck Cancer:<br />
ERBITUX (Cetuximab), in combination with radiation therapy, is indicated for the initial treatment of a certain type of locally or regionally advanced head and neck cancer.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.medicalapple.com/blog/admin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

